Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 01, 2010 (Vol. 30, No. 9)

Driving Successful Assay Development

Host of Therapeutic Classes Require Continuous Updating of Technology

  • Since biological therapeutics are derived from living organisms, their manufacture and validation presents difficulties not encountered during traditional small molecule drug development. Despite the complexities inherent in developing biologics, there are a growing number of licensed biological products on the market.  IBC’s “Bioassay and Development” meeting held earlier ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.